Eli Lilly picks up another Covid-19 EUA as regulators wave through its Olumiant plus...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Nov 19, 2020 at 11:22 PM.

  1. #1 cafead, Nov 19, 2020 at 11:22 PM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,044
    Likes Received:
    3
    via Eli Lilly has picked up another win at the FDA, crossing the finish line again in the Covid-19 treatment race despite some mixed data. And the authorization comes before Regeneron’s antibody therapy, which notably was used to treat President Donald Trump back in October, could pick up an EUA.

    article source
     
    Quote

Reply to Thread